Vimarsana
Biggest News Aggregation in the World

Cure Genetics News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Cure Genetics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Cure Genetics Today - Breaking & Trending Today

China Tech Digest: China's 'Sky Eye' FAST Detects About 500 New Pulsars; Chinese Residents Can Order Food Deliveries In Digital RMB – China Money Network - Vimarsana News

China Tech Digest: China's 'Sky Eye' FAST Detects About 500 New Pulsars; Chinese Residents Can Order Food Deliveries In Digital RMB – China Money Network

China’s ‘Sky Eye’ FAST detects about 500 new pulsars The Chinese Academy of Sciences recently held a press conference to unveil the operation conditions ... Beijing, Blue Ocean Capital Group, Oriza, Shanghai, shenzhen

China Digest: Cure Genetics nets $60m; Atom Bioscience raises over $47m - Vimarsana News

China Digest: Cure Genetics nets $60m; Atom Bioscience raises over $47m

China-based biotech startup Cure Genetics and pharmaceutical firm Atom Bioscience have raised new funding.

Cure Genetics Collaborates with Boehringer Ingelheim to Develop Novel AAV Vectors Enabling the Next-generation Liver-targeted Gene Therapy - Vimarsana News

Cure Genetics Collaborates with Boehringer Ingelheim to Develop Novel AAV Vectors Enabling the Next-generation Liver-targeted Gene Therapy

Share this article Share this article SUZHOU, China, Jan. 18, 2021 /PRNewswire/ -- Cure Genetics announced a collaboration with Boehringer Ingelheim to develop novel Adeno-Associated Virus (AAV) vectorsleveraging Cure Genetics' proprietary VELP TM platform to develop next-generation gene therapies. This new collaboration combines Boehringer Ingelheim's experience in disease biology and gene therapy development with Cure Genetics' AAV expertise in library construction and highly efficient in vivo AAV screening. The aim is to provide potential new AAV serotypes for patients. The clinical appl...